Neuralink is a neurotechnology company founded by Elon Musk in 2016 with the goal of developing implantable brain-machine interfaces. In August 2020, the company announced that it had successfully implanted a chip in a pig’s brain, allowing the pig to move a cursor on a computer screen using its snout.
In November 2020, Neuralink announced that it had successfully implanted a chip in a monkey, enabling the monkey to control a computer with its brain. The company plans to begin human trials in the near future. In July 2021, Neuralink announced it was testing a device that can be implanted via a small hole in the skull, which would be a less invasive surgery than traditional brain implants.
Neuralink has not yet begun human trials for its brain-machine interface technology. The company has stated that it plans to begin human trials in the near future but has not given a specific timeline for when these trials will begin. The company has also not disclosed much information about the specific details of the trial, such as the number of participants or what the trial will entail.
The company has stated that it plans to use the technology initially to help people with severe spinal cord injuries, brain injuries, and neurodegenerative diseases such as Parkinson’s, Alzheimer’s, and ALS. The hope is that the technology will eventually be able to help with a wide range of conditions and improve the quality of life for people with a wide range of disabilities.
It’s worth noting that human trials for neural implants are a complicated process and that it’s not clear yet when Neuralink will be able to start them. Additionally, It’s important to note that the regulatory approval process for neurotechnologies is complex, and it could take several years before the company’s products are cleared for use in humans.
For more such content, keep reading @techinnews